Lessons from Leishmania: a model for investigations of CD4+ subset differentiation
- PMID: 1365527
Lessons from Leishmania: a model for investigations of CD4+ subset differentiation
Abstract
Infection of inbred mice with Leishmania major remains the best model of human infection with visceralizing Leishmania that cause kala-azar. Immunologic investigations have correlated the outcome of disease with expansion of different subsets of CD4+ cells, designated Th1 and Th2. Although the capacity of fixed effector Th1 and Th2 populations to mediate the diverse outcomes of disease through the release of soluble cytokines, particularly IFN-gamma and IL-4, has been demonstrated, the mechanisms by which these subsets become established during infection have not been delineated. This review focuses on known features of CD4+ differentiation using other experimental models, and proposes that genetic susceptibility to Leishmania can occur if the host has a Th2 precursor cell in the memory configuration prior to the time of exposure to organisms, perhaps in response to cross-reactive self-peptides. The hypothesis can explain a number of puzzling observations in both murine and human disease due to these organisms and makes several predictions amenable to experimental testing.
Similar articles
-
The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.J Immunol. 1997 Feb 15;158(4):1559-64. J Immunol. 1997. PMID: 9029090
-
Regulator and effector functions of T-cell subsets in human Leishmania infections.APMIS Suppl. 1997;68:1-33. APMIS Suppl. 1997. PMID: 9063493
-
Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th subset differentiation.Eur J Dermatol. 2002 Jul-Aug;12(4):316-8. Eur J Dermatol. 2002. PMID: 12095873 Review.
-
Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.J Immunol. 1995 Apr 15;154(8):3779-87. J Immunol. 1995. PMID: 7706719
-
Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.Behring Inst Mitt. 1997 Feb;(98):153-9. Behring Inst Mitt. 1997. PMID: 9382736 Review.
Cited by
-
A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis.Vaccine. 2009 Feb 11;27(7):1080-6. doi: 10.1016/j.vaccine.2008.11.094. Epub 2008 Dec 16. Vaccine. 2009. PMID: 19095029 Free PMC article. Clinical Trial.
-
Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.Clin Exp Immunol. 1994 Jun;96(3):416-21. doi: 10.1111/j.1365-2249.1994.tb06044.x. Clin Exp Immunol. 1994. PMID: 8004810 Free PMC article.
-
Immunoblot analysis of Leishmania panamensis antigens in sera of patients with American cutaneous leishmaniasis.J Clin Microbiol. 1997 Dec;35(12):3043-7. doi: 10.1128/jcm.35.12.3043-3047.1997. J Clin Microbiol. 1997. PMID: 9399491 Free PMC article.
-
Tolerance to staphylococcal enterotoxin B initiated Th1 cell differentiation in mice infected with Candida albicans.Infect Immun. 1994 Sep;62(9):4047-53. doi: 10.1128/iai.62.9.4047-4053.1994. Infect Immun. 1994. PMID: 7914883 Free PMC article.
-
Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania.Front Immunol. 2015 Oct 13;6:524. doi: 10.3389/fimmu.2015.00524. eCollection 2015. Front Immunol. 2015. PMID: 26528287 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials